PH31424A - Tricyclic pyrazole derivatives. - Google Patents
Tricyclic pyrazole derivatives.Info
- Publication number
- PH31424A PH31424A PH51087A PH51087A PH31424A PH 31424 A PH31424 A PH 31424A PH 51087 A PH51087 A PH 51087A PH 51087 A PH51087 A PH 51087A PH 31424 A PH31424 A PH 31424A
- Authority
- PH
- Philippines
- Prior art keywords
- pyrazole derivatives
- lower alkyl
- tricyclic pyrazole
- tricyclic
- alkoxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Reproductive Health (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Addiction (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH249094 | 1994-08-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
PH31424A true PH31424A (en) | 1998-10-29 |
Family
ID=4234975
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH51087A PH31424A (en) | 1994-08-12 | 1995-08-10 | Tricyclic pyrazole derivatives. |
Country Status (31)
Country | Link |
---|---|
US (1) | US5561150A (no) |
EP (1) | EP0700905B1 (no) |
JP (1) | JP2755560B2 (no) |
KR (1) | KR100385384B1 (no) |
CN (1) | CN1056607C (no) |
AT (1) | ATE207905T1 (no) |
AU (1) | AU691310B2 (no) |
BR (1) | BR9503630A (no) |
CA (1) | CA2153937C (no) |
CO (1) | CO4410331A1 (no) |
CZ (1) | CZ289027B6 (no) |
DE (1) | DE59509777D1 (no) |
DK (1) | DK0700905T3 (no) |
ES (1) | ES2164730T3 (no) |
FI (1) | FI113264B (no) |
HK (1) | HK1012342A1 (no) |
HU (1) | HUT72066A (no) |
IL (1) | IL114849A (no) |
MA (1) | MA23643A1 (no) |
MY (1) | MY133619A (no) |
NO (1) | NO305026B1 (no) |
NZ (1) | NZ272731A (no) |
PE (1) | PE34096A1 (no) |
PH (1) | PH31424A (no) |
PL (1) | PL182480B1 (no) |
PT (1) | PT700905E (no) |
RU (1) | RU2152388C1 (no) |
TR (1) | TR199500977A2 (no) |
TW (1) | TW403738B (no) |
UY (1) | UY24016A1 (no) |
ZA (1) | ZA956553B (no) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU727654B2 (en) * | 1997-06-13 | 2000-12-21 | Yamanouchi Pharmaceutical Co., Ltd. | Tricyclic pyrazole derivative |
US7189753B1 (en) | 1997-11-06 | 2007-03-13 | Cady Roger K | Preemptive prophylaxis of migraine |
US6960579B1 (en) | 1998-05-19 | 2005-11-01 | Alcon Manufacturing, Ltd. | Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders |
GB9819019D0 (en) * | 1998-09-01 | 1998-10-28 | Cerebrus Ltd | Chemical compounds II |
GB9820767D0 (en) * | 1998-09-23 | 1998-11-18 | Cerebrus Ltd | Chemical compounds VIII |
GB9918965D0 (en) * | 1999-08-11 | 1999-10-13 | Cerebrus Ltd | Chemical compounds xxi |
GB9918962D0 (en) * | 1999-08-11 | 1999-10-13 | Cerebrus Ltd | Chemical compounds xxii |
US20040048844A1 (en) * | 1999-10-20 | 2004-03-11 | Bristol-Myers Squibb Pharma Company | Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents |
US6291504B1 (en) * | 1999-10-20 | 2001-09-18 | Dupont Pharmaceuticals Company | Acylsemicarbazides and their uses |
EP1132389A1 (en) | 2000-03-06 | 2001-09-12 | Vernalis Research Limited | New aza-indolyl derivatives for the treatment of obesity |
DE60117247D1 (de) * | 2000-03-31 | 2006-04-20 | Purdue Research Foundation West Lafayette | Phosphoramidat-prodrugs |
WO2004098807A1 (en) * | 2000-11-21 | 2004-11-18 | Barsplice Products, Inc. | Method of making steel couplers for joining concrete reinforcing bars |
JP2005506280A (ja) | 2000-12-20 | 2005-03-03 | ブリストル−マイヤーズ・スクイブ・ファーマ・カンパニー | アリールおよびアミノアリール置換セロトニン受容体アゴニストおよびアンタゴニストリガンド |
EP1392658A4 (en) * | 2001-06-01 | 2004-10-13 | Alcon Inc | NOVEL FUSED INDAZOLES AND INDOLES AND THEIR USE IN THE TREATMENT OF GLAUCOMES |
JP2004535418A (ja) * | 2001-06-01 | 2004-11-25 | アルコン,インコーポレイテッド | ピラノインダゾールおよび緑内障治療への使用 |
US6884816B2 (en) * | 2001-08-31 | 2005-04-26 | Alcon, Inc. | Hydroxy substituted fused naphthyl-azoles and fused indeno-azoles and their use for the treatment of glaucoma |
US20060269611A1 (en) * | 2001-11-29 | 2006-11-30 | Steiner Mitchell S | Prevention and treatment of androgen-deprivation induced osteoporosis |
US20080249183A1 (en) * | 2001-11-29 | 2008-10-09 | Steiner Mitchell S | Treatment of androgen-deprivation induced osteoporosis |
US20070197664A1 (en) * | 2001-11-29 | 2007-08-23 | Steiner Mitchell S | Prevention and treatment of androgen-deprivation induced osteoporosis |
US20040214898A1 (en) * | 2001-11-29 | 2004-10-28 | Steiner Mitchell S. | Methods for treating hot flashes |
US20050080143A1 (en) * | 2001-11-29 | 2005-04-14 | Steiner Mitchell S. | Treatment of androgen-deprivation induced osteoporosis |
TW593302B (en) * | 2001-12-20 | 2004-06-21 | Alcon Inc | Novel benzodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma |
WO2003057161A2 (en) * | 2001-12-28 | 2003-07-17 | Bayer Pharmaceuticals Corporation | BENZOTHIENO [3,2-c]PYRAZOLYL AND BENZOFURANO [3,2-c] PYRAZOLYL COMPOUNDS, THEIR USE IN DISEASES ASSOCIATED WITH THE 5-HT2C RECEPTOR AND INTERMEDIATE COMPOUNDS THEREOF |
WO2003057673A1 (en) * | 2001-12-28 | 2003-07-17 | Bayer Pharmaceuticals Corporation | 1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor |
WO2003057674A1 (en) * | 2001-12-28 | 2003-07-17 | Bayer Pharmaceuticals Corporation | 4-sulfide / sulfoxide / sulfonyl-1h-pyrazolyl derivative compounds, for use in diseases associated with the 5-ht2c receptor |
PL375564A1 (en) * | 2002-08-30 | 2005-11-28 | Alcon, Inc. | Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma |
WO2004054572A2 (en) * | 2002-12-13 | 2004-07-01 | Alcon, Inc. | Novel benzopyran analogs and their use for the treatment of glaucoma |
WO2005053688A1 (en) * | 2003-11-26 | 2005-06-16 | Alcon, Inc. | Substituted furo[2,3-g] indazoles for the treatment of glaucoma |
US7129257B1 (en) | 2003-12-15 | 2006-10-31 | Alcon, Inc. | Pyrazolo[3,4- e]benzoxazoles for the treatment of glaucoma |
US7338972B1 (en) | 2003-12-15 | 2008-03-04 | Alcon, Inc. | Substituted 1-alkylamino-1H-indazoles for the treatment of glaucoma |
AR046890A1 (es) * | 2003-12-15 | 2005-12-28 | Alcon Inc | [1,4] oxazino [2,3-g] indazoles sustituidos para el tratamiento del glaucoma. |
WO2006062839A1 (en) * | 2004-12-08 | 2006-06-15 | Alcon, Inc. | Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma |
TW200744567A (en) * | 2005-09-23 | 2007-12-16 | Alcon Inc | Phenylethylamine analogs and their use for treating glaucoma |
WO2007149728A2 (en) * | 2006-06-20 | 2007-12-27 | Alcon Research, Ltd. | Aryl and heteroaryl tetrahydrobenzazepine derivatives and their use for treating glaucoma |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US392430A (en) * | 1888-11-06 | Tubular lantern | ||
GB1228792A (no) * | 1967-07-20 | 1971-04-21 | ||
BE789948A (fr) * | 1971-10-13 | 1973-04-11 | Sandoz Sa | Nouveaux derives du pyrazole, leur preparation et leur application comme medicaments |
-
1995
- 1995-07-10 TW TW084107125A patent/TW403738B/zh not_active IP Right Cessation
- 1995-07-14 CA CA002153937A patent/CA2153937C/en not_active Expired - Fee Related
- 1995-08-02 US US08/510,153 patent/US5561150A/en not_active Expired - Lifetime
- 1995-08-04 HU HU9502310A patent/HUT72066A/hu unknown
- 1995-08-04 EP EP95112270A patent/EP0700905B1/de not_active Expired - Lifetime
- 1995-08-04 ES ES95112270T patent/ES2164730T3/es not_active Expired - Lifetime
- 1995-08-04 ZA ZA956553A patent/ZA956553B/xx unknown
- 1995-08-04 AT AT95112270T patent/ATE207905T1/de not_active IP Right Cessation
- 1995-08-04 PT PT95112270T patent/PT700905E/pt unknown
- 1995-08-04 DK DK95112270T patent/DK0700905T3/da active
- 1995-08-04 DE DE59509777T patent/DE59509777D1/de not_active Expired - Fee Related
- 1995-08-07 AU AU28382/95A patent/AU691310B2/en not_active Ceased
- 1995-08-07 NZ NZ272731A patent/NZ272731A/en unknown
- 1995-08-07 IL IL11484995A patent/IL114849A/xx not_active IP Right Cessation
- 1995-08-07 CZ CZ19952013A patent/CZ289027B6/cs not_active IP Right Cessation
- 1995-08-08 MA MA23984A patent/MA23643A1/fr unknown
- 1995-08-08 TR TR95/00977A patent/TR199500977A2/xx unknown
- 1995-08-08 RU RU95113149/04A patent/RU2152388C1/ru not_active IP Right Cessation
- 1995-08-08 PE PE1995275579A patent/PE34096A1/es not_active Application Discontinuation
- 1995-08-09 JP JP7203040A patent/JP2755560B2/ja not_active Expired - Fee Related
- 1995-08-10 PH PH51087A patent/PH31424A/en unknown
- 1995-08-10 MY MYPI95002335A patent/MY133619A/en unknown
- 1995-08-10 CO CO95035750A patent/CO4410331A1/es unknown
- 1995-08-10 PL PL95309974A patent/PL182480B1/pl unknown
- 1995-08-10 CN CN95115544A patent/CN1056607C/zh not_active Expired - Fee Related
- 1995-08-10 KR KR1019950024636A patent/KR100385384B1/ko not_active IP Right Cessation
- 1995-08-11 FI FI953827A patent/FI113264B/fi not_active IP Right Cessation
- 1995-08-11 NO NO953162A patent/NO305026B1/no unknown
- 1995-08-11 BR BR9503630A patent/BR9503630A/pt not_active IP Right Cessation
- 1995-08-11 UY UY24016A patent/UY24016A1/es unknown
-
1998
- 1998-12-15 HK HK98113447A patent/HK1012342A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1012342A1 (en) | Tricyclic pyrazole derivatives | |
EP0776327A4 (en) | NEW MULTIMERIZATION AGENTS | |
MY119150A (en) | Azetidine derivatives, their preparation and medicaments containing them | |
AU658781B2 (en) | Substituted azoles and processes for the preparation thereof | |
IL113901A (en) | 1-Phenyl-3- dimethylaminopropane derivatives their preparation and pharmacemtical compositions containing them | |
IL69912A (en) | Substituted 1-hydroxyethyltriazolyl derivatives,their preparation and their use as plant protection agents | |
YU49175B (sh) | Postupak za dobijanje derivata bakatina iii i 10-dezacetil-bakatina iii | |
ZA831226B (en) | Novel derivatives of psoralen | |
ES8802222A1 (es) | Un procedimiento para preparar derivados de vinilisoquinolina | |
ZA911767B (en) | Urea derivatives,their preparation and medicinal products containing them | |
ES8607935A1 (es) | Un procedimiento de preparar un derivado de ariltio-piridi- nil-alcanol | |
HU9600300D0 (en) | Thiocarbamoyl derivatives using as antimicrobial agents and process for producing of these | |
EP0443474A3 (en) | 1-phenoxycarbonyl-2-pyrrolidinone derivatives and nootropic agents | |
MX9605208A (es) | Nuevos derivados de eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos. |